{"id":"tp-55494","type":"article-newspaper","title":"PepGen Prices 25 Million Shares at $5 in $125 Million Offering","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/55494","datePublished":"2026-11-12T14:22:03.000Z","dateModified":"2026-11-12T14:22:03.000Z","language":"en","abstract":"The clinical-stage biotech expects $125 million in gross proceeds before underwriting discounts, commissions and offering expenses. Underwriters have a 30-day option to buy up to 3.75 million more shares.","section":"Business","references":[{"title":"Nov. 10 proposal for a $125 million stock and warrant offering","url":"https://www.tokenpost.com/news/business/54424"}]}